Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.

A widely prescribed medication for underactive thyroid, levothyroxine, is potentially associated with bone loss, according to a study set for presentation at the Radiological Society of North ...

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

A widely used pill for treating an underactive thyroid may be associated with bone loss, according to a study being presented ...

New research indicates a link between levothyroxine and bone mass loss in older adults. Scientists emphasize the need to ...

New research indicates a link between levothyroxine and bone mass loss in older adults. Scientists emphasise the need to ...

Levothyroxine, commercially known as Synthroid among other names, is commonly used to treat an underactive thyroid.

After an average follow-up period of 6.3 years, older adults on levothyroxine had a greater loss of both total body bone mass and bone density.

ONE of the most commonly prescribed drugs in the UK, used to treat a hormone condition, may be linked to a bone snapping ...